An immunoassay that distinguishes real neuromyelitis optica signals from a labeling detected in patients receiving natalizumab
Crossref DOI link: https://doi.org/10.1186/1471-2377-14-139
Published: 2014-12
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Sánchez Gomar, Ismael
Díaz Sánchez, María
Uclés Sánchez, Antonio José
Casado Chocán, José Luis
Ramírez-Lorca, Reposo
Serna, Ana
Villadiego, Javier
Toledo-Aral, Juan José
Echevarría, Miriam
unspecified valid from 2014-07-01